| Dr Gregory Wei Chiang Woo, MD | |
|
680 Centre St, Brockton, MA 02302-3308 | |
| (508) 941-7000 | |
| (508) 941-6480 |
| Full Name | Dr Gregory Wei Chiang Woo |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 680 Centre St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093910788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 248062 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brockton Neighborhood Health Center | 3870491699 | 64 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Brockton Neighborhood Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225085319 PECOS PAC ID: 3870491699 Enrollment ID: O20031230000558 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Signature Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508804949 PECOS PAC ID: 7719876267 Enrollment ID: O20040312000372 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Brockton Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063431286 PECOS PAC ID: 4082504733 Enrollment ID: O20040317000871 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Lowell Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952307530 PECOS PAC ID: 6204807944 Enrollment ID: O20040804001749 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Lgh Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174698385 PECOS PAC ID: 3173626751 Enrollment ID: O20070320000453 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Circle Health Obgyn, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912179870 PECOS PAC ID: 1052483476 Enrollment ID: O20080630000642 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Obhg Massachusetts Lowell Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861036451 PECOS PAC ID: 0244667574 Enrollment ID: O20200227000344 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Entity Name | Obhg Massachusetts - Direct Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487229035 PECOS PAC ID: 1456752609 Enrollment ID: O20210625001903 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Wei Chiang Woo, MD 7 Goodrich Rd, Sturbridge, MA 01566-1140 Ph: (508) 941-7000 | Dr Gregory Wei Chiang Woo, MD 680 Centre St, Brockton, MA 02302-3308 Ph: (508) 941-7000 |
News Archive
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, today announced it will exhibit at the 2010 Annual HIMSS Conference and Exhibit, March 1- 4, 2010, in Atlanta at the Georgia World Congress Center. At the event, Healthland will conduct product demonstrations including its new Emergency Department Information System and Healthland Analytics, report results from a recent customer survey about the American Recovery and Reinvestment Act (ARRA) and meaningful use, and announce recent client success stories.
A major international study has found that 2.6 percent of infants and children hospitalized for stroke die in the hospital.
Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
› Verified 3 days ago
Zwi Hoch, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Pearl St, Suite 2500, Brockton, MA 02301 Phone: 508-897-6111 Fax: 508-897-6115 | |
Brooke J Bloom, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 650 Centre St, Brockton, MA 02302 Phone: 508-697-8666 | |
Dr. Shenbagavalli Ramaswami, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 830 Oak St, Brockton, MA 02301 Phone: 781-585-9522 Fax: 781-585-9544 | |
Ana-cristina Vasilescu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 235 N Pearl St, Brockton, MA 02301 Phone: 508-427-3000 | |
Gautam B Parikh, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 830 Oak St, Suite 201w, Brockton, MA 02301 Phone: 508-897-4740 Fax: 508-897-4749 | |
Soheil Amin-hanjani, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Oak St, Suite 201w, Brockton, MA 02301 Phone: 508-583-4961 |